Autopsy report · NCT05789524
The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B
Cause of deathFunding or business
“Study terminated due to business and strategic decision”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 8 months before it stopped.
- 60 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- ApcinteX Ltd
- Sponsor type
- Industry
- Conditions
- Hemophilia a; Hemophilia B
- Interventions
- SerpinPC
- Participants
- 60
- Sites
- 59
- Countries
- Armenia, Australia, Belgium, Canada, France, Germany, India, Italy, Poland, South Africa, Spain, Taiwan and more
Trials that died the same way
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
“Study terminated for strategic business reasons” - Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
“Study terminated due to business decision” - Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer
“Study terminated due to business priorities” - Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
“The study was terminated due to a business decision.” - A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis
“The study was terminated due to strategic business reasons.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.